Kaleo

This Asthma & Allergy Awareness Month, we’re proud to sponsor premiere events for “May Contain,” the award-winning docudrama highlighting the real experiences of children and families navigating food allergies and anaphylaxis. Learn more: bit.ly/3RCl6b7

Food allergy bullying is more common than many realize & often goes unspoken. As conversations around food allergies continue this May, this episode of The Itch Podcast explores the signs & how to start meaningful conversations with children and schools. bit.ly/48d0BHA

Food Allergy Awareness Month is here. FAACT's #InvisibleNoMore campaign offers educational resources and tools to help patients, families, and communities raise awareness of food allergy safety. Explore the campaign and get involved. bit.ly/4ezqrcY

Kaléo’s Medical Affairs team will be attending the Pediatric Academic Societies (PAS) meeting in Boston this April. If you’ll be there, stop by booth 327 to connect.

The Kaléo team will be at CBRNe Convergence Canada 2026. Attending? Let’s connect about device innovation and real-world usability in critical environments.

One platform. Three configurations. The Aerio™ Auto-Injector Platform is designed to meet the highest standards of device function and form while supporting a range of drug delivery needs: Aerio™Uno Aerio™Duo Aerio™Mix Learn more: kaleo.com/aerio/ #BuiltToTrust

One platform. Three configurations. The Aerio™ Auto-Injector Platform is designed to meet the highest standards of device function and form while supporting a range of drug delivery needs: Aerio™Uno Aerio™Duo Aerio™Mix Learn more: kaleo.com/aerio/ #BuiltToTrust

Recognizing anaphylaxis in infants and toddlers can be challenging since symptoms may look different than in older children. The Recognizing Anaphylaxis in Infants and Toddlers infographic from @AllergyAsthmaHQ outlines what to look for: bit.ly/4lnhSD6

Innovation doesn’t start in the lab. It starts with people. From early design to final production, each version of the Aerio™ auto-injector platform is designed to meet the real-world needs of patients and our partners. Learn more: kaleo.com/aerio #BuiltToTrust

@AllergyAsthmaHQ Grateful to collaborate with you in support of this important work.

Recognizing anaphylaxis in infants and toddlers can be especially challenging. Symptoms don’t always present the same way they do in older children or adults and early signs can be subtle. From belly breathing and nasal flaring to unusual crankiness, sudden fatigue, or limpness, understanding what to look for can make a life-saving difference. That’s why we developed the Infant Anaphylaxis Symptom Recognition Guide, a practical resource to help caregivers, healthcare professionals, and childcare providers identify both mild and severe symptoms and understand when to use epinephrine. We encourage you to share with your networks to download this guide and keep it alongside their Allergy & Anaphylaxis Emergency Plan. 🔗 Download here: store.allergyasthmanetwork.org/recognizing-an… ¡También disponible en español! store.allergyasthmanetwork.org/recognizing-an… Special thanks to @kaleo for their support.

We’re looking forward to connecting with the allergy and immunology community and being part of the important conversations taking place around research, education, and patient care. If you’re attending, we hope to see you there! #AAAAI26

25 years of Kaléo. Since 2000, our mission has focused on providing patients with the security and peace of mind that can only come when human ingenuity precisely meets human need. Read more: bit.ly/3ZHxhUX #BuiltToTrust

Our MCM team is heading to Lyon for Intelligence-SEC CBRNe Summit Europe 2026 from February 3-5. Come visit us at the booth to learn more about our medical countermeasure capabilities. kaleo.com/mcm

Great to see Kaléo highlighted in European Security & Defence Magazine for our role in advancing medical countermeasures that support CBRN preparedness. Read the article: bit.ly/4oLyWmG

Leadership update: Kaléo welcomes Ram Halthore as VP, Development, joining Carrie Siragusa, CPA, VP, Marketing & PR - strengthening our focus on innovation, growth, and preparedness. Full announcement: bit.ly/3LH5SyY

Kaléo’s Aerio™ platform is built for real-world needs, supporting large-volume and high-viscosity formulations with a compact, easy-to-use design. Learn more: kaleo.com/aerio

In 2026, Kaléo remains committed to advancing solutions that protect and empower communities worldwide. Wishing you a year of progress, health, and possibility.

As 2025 wraps up, we’re proud to support the Early Childhood Anaphylaxis Collaborative & excited for what’s ahead in 2026. Join today to help shape what's next & support early childcare centers in managing anaphylaxis: bit.ly/40YK46y #ECACollaborativePartner #childcare

Honored to celebrate the Elijah-Alavi Foundation @Elijahsecho at yesterday’s NYC bill signing. The new legislation builds on Elijah’s Law to expand access to weight-based epinephrine and staff training in all city schools and childcare programs.

This Thanksgiving, we’re grateful for our partners, colleagues, and communities working together to make a difference. Wishing you and your loved ones a safe and happy holiday.